Bronwyn Kivell

Bronwyn Kivell

Victoria University of Wellington

H-index: 28

Oceania-New Zealand

About Bronwyn Kivell

Bronwyn Kivell, With an exceptional h-index of 28 and a recent h-index of 21 (since 2020), a distinguished researcher at Victoria University of Wellington,

His recent articles reflect a diverse array of research interests and contributions to the field:

KAPPA OPIOID RECEPTOR AGONISTS MODULATE THE ANTI-INFLAMMATORY ACTIONS OF MICROGLIA AND PROMOTE OLIGODENDROCYTE MATURATION AND MYELIN REPAIR IN PRECLINICAL MODELS OF MULTIPLE …

The kappa opioid receptor agonist 16-bromo salvinorin a has anti-cocaine effects without significant effects on locomotion, food reward, learning and memory, or anxiety and …

Treatment of demyelinating diseases

Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune‐driven demyelination

The kappa opioid receptor: a promising therapeutic target for multiple pathologies

Sex differences in kappa opioid receptor agonist mediated attenuation of chemotherapy-induced neuropathic pain in mice

The imidazodiazepine, KRM-II-81: an example of a newly emerging generation of GABAkines for neurological and psychiatric disorders

Sex differences in the behavioural aspects of the cuprizone-induced demyelination model in mice

Bronwyn Kivell Information

University

Position

___

Citations(all)

2325

Citations(since 2020)

1087

Cited By

1690

hIndex(all)

28

hIndex(since 2020)

21

i10Index(all)

45

i10Index(since 2020)

35

Email

University Profile Page

Victoria University of Wellington

Google Scholar

View Google Scholar Profile

Top articles of Bronwyn Kivell

Title

Journal

Author(s)

Publication Date

KAPPA OPIOID RECEPTOR AGONISTS MODULATE THE ANTI-INFLAMMATORY ACTIONS OF MICROGLIA AND PROMOTE OLIGODENDROCYTE MATURATION AND MYELIN REPAIR IN PRECLINICAL MODELS OF MULTIPLE …

IBRO Neuroscience Reports

Bronwyn Kivell

Rabia Bibi

Bria Pengelly

Ross Van De Wetering

Kelly Paton

...

2023/10/1

The kappa opioid receptor agonist 16-bromo salvinorin a has anti-cocaine effects without significant effects on locomotion, food reward, learning and memory, or anxiety and …

Molecules

Ross van de Wetering

Amy Ewald

Susan Welsh

Lindsay Kornberger

Samuel E Williamson

...

2023/6/19

Treatment of demyelinating diseases

2023/3/30

Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune‐driven demyelination

Clinical & Translational Immunology

Katharina Robichon

Rabia Bibi

Mackenzie Kiernan

Lisa Denny

Thomas E Prisinzano

...

2023

The kappa opioid receptor: a promising therapeutic target for multiple pathologies

Martin L Dalefield

Brittany Scouller

Rabia Bibi

Bronwyn M Kivell

2022/6/20

Sex differences in kappa opioid receptor agonist mediated attenuation of chemotherapy-induced neuropathic pain in mice

Frontiers in Pharmacology

Kelly F Paton

Dan Luo

Anne C La Flamme

Thomas E Prisinzano

Bronwyn M Kivell

2022/2/18

The imidazodiazepine, KRM-II-81: an example of a newly emerging generation of GABAkines for neurological and psychiatric disorders

Jeffrey M Witkin

Arnold Lippa

Jodi L Smith

Xiaoming Jin

Xingjie Ping

...

2022/2/1

Sex differences in the behavioural aspects of the cuprizone-induced demyelination model in mice

Brain Sciences

Kelly F Paton

Sheein Hong

Andrew Biggerstaff

Bronwyn M Kivell

2022/12/8

Agonists of the mu opioid receptor

2021/6/15

The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain

Neuropharmacology

Diana Vivian Atigari

Kelly Frances Paton

Rajendra Uprety

András Váradi

Amy Frances Alder

...

2021/3/1

Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease

Clinical & translational immunology

Lisa Denny

Afnan Al Abadey

Katharina Robichon

Nikki Templeton

Thomas E Prisinzano

...

2021

The Salvinorin analogue, Ethoxymethyl ether Salvinorin B, promotes Remyelination in preclinical models of multiple sclerosis

Frontiers in neurology

Kelly F Paton

Katharina Robichon

Nikki Templeton

Lisa Denny

Afnan Al Abadey

...

2021/12/20

Oxidative metabolism as a modulator of kratom’s biological actions

Journal of medicinal chemistry

Soumen Chakraborty

Rajendra Uprety

Samuel T Slocum

Takeshi Irie

Valerie Le Rouzic

...

2021/11/16

The α2, 3-selective potentiators of GABAA receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without …

Pharmacology Biochemistry and Behavior

A Biggerstaff

B Kivell

JL Smith

Md Y Mian

LK Golani

...

2020/9/1

Evaluation of biased and balanced salvinorin A analogs in preclinical models of pain

Frontiers in Neuroscience

Kelly F Paton

Andrew Biggerstaff

Sophia Kaska

Rachel S Crowley

Anne C La Flamme

...

2020/7/21

Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-protein …

Bioorganic & medicinal chemistry letters

Kenneth G Holden

Kevin Tidgewell

Alfred Marquam

Richard B Rothman

Hernán Navarro

...

2007/11/15

Strategies for developing κ opioid receptor agonists for the treatment of pain with fewer side effects

Kelly F Paton

Diana V Atigari

Sophia Kaska

Thomas Prisinzano

Bronwyn M Kivell

2020/11/1

N‐docosahexaenoyl ethanolamine (synaptamide) has antinociceptive effects in male mice

European Journal of Pain

Kelly F Paton

Rahau Shirazi

Mikhail Vyssotski

Bronwyn M Kivell

2020/11

See List of Professors in Bronwyn Kivell University(Victoria University of Wellington)

Co-Authors

H-index: 61
Harald H. Sitte

Harald H. Sitte

Medizinische Universität Wien

H-index: 51
Tom Prisinzano

Tom Prisinzano

University of Kentucky

H-index: 49
Marta Filizola

Marta Filizola

Icahn School of Medicine at Mount Sinai

H-index: 46
Peter Northcote

Peter Northcote

Victoria University of Wellington

H-index: 10
Peter J Bosch

Peter J Bosch

University of Iowa

academic-engine